87
Views
10
CrossRef citations to date
0
Altmetric
Review

Clinical implications of aspirin resistance

&
Pages 969-975 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lennart R. F. Blomqvist, Annika M. Strandell, Anders Jeppsson & Margareta S. E. Hellgren. (2022) Arachidonic acid-induced platelet aggregation and acetylsalicylic acid treatment during pregnancy in women with recurrent miscarriage, a post hoc study. Platelets 33:2, pages 278-284.
Read now
Eugene Lin, Rajiv Padmanabhan & Majaz Moonis. (2010) Antiplatelet agents and proton pump inhibitors – personalizing treatment. Pharmacogenomics and Personalized Medicine 3, pages 101-109.
Read now

Articles from other publishers (8)

Matthew M. Finneran, Veronica M. Gonzalez-Brown, Devin D. Smith, Mark B. Landon & Kara M. Rood. (2019) Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin. American Journal of Obstetrics and Gynecology 220:4, pages 385.e1-385.e6.
Crossref
Emad Ahmed & Ayman El-Menyar. (2015) Management of Coronary Artery Disease in South Asian Populations. Angiology 67:3, pages 212-223.
Crossref
Yukio Kimura, Katsuhiro Takano, Kaneo Satoh, Kaoru Aida, Tetsuro Kobayashi & Yukio Ozaki. (2013) Aspirin Half Maximal Inhibitory Concentration Value on Platelet Cyclooxygenase1 in Severe Type-2 Diabetes Mellitus is not Significantly Different from that of Healthy Individuals. Clinical and Applied Thrombosis/Hemostasis 20:6, pages 629-636.
Crossref
Sarah Kraus, Simone Hummler, Adetunji T. Toriola, Elizabeth M. Poole, Dominique Scherer, Jana Kotzmann, Karen W. Makar, Dina Kazanov, Lior Galazan, Inna Naumov, Anna E. Coghill, David Duggan, Biljana Gigic, Nadir Arber & Cornelia M. Ulrich. (2013) Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial. Pharmacogenetics and Genomics 23:8, pages 428-437.
Crossref
David M. Greer. (2010) Aspirin and Antiplatelet Agent Resistance. CNS Drugs 24:12, pages 1027-1040.
Crossref
David G. Menter, Richard L. Schilsky & Raymond N. DuBois. (2010) Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward. Clinical Cancer Research 16:5, pages 1384-1390.
Crossref
Justin R. Hamilton. (2009) Protease-activated receptors as targets for antiplatelet therapy. Blood Reviews 23:2, pages 61-65.
Crossref
R. Charles Callison & Harold P. AdamsJr.Jr.. (2008) Use of Antiplatelet Agents for Prevention of Ischemic Stroke. Neurologic Clinics 26:4, pages 1047-1077.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.